All Stories

  1. The third international meeting on genetic disorders in the RAS/MAPK pathway: Towards a therapeutic approach

    Article • American Journal of Medical Genetics Part A, April 2015, Wiley

    Reymundo Lozano

  2. Methadone use in a male with theFMRIpremutation and FXTAS

    Article • American Journal of Medical Genetics Part A, April 2015, Wiley

    Reymundo Lozano

  3. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment

    Article • European Journal of Human Genetics, April 2015, Springer Science + Business Media

    Reymundo Lozano

  4. Fragile X-Associated Disorders

    Article • January 2015, Elsevier

    Reymundo Lozano

  5. Modulation of the GABAergic pathway for the treatment of fragile X syndrome

    Article • September 2014, Taylor & Francis

    Dr Reymundo Lozano, Reymundo Lozano

  6. Genomic studies in fragile X premutation carriers

    Article • Journal of Neurodevelopmental Disorders, July 2014, Springer Science + Business Media

    Dr Reymundo Lozano, Reymundo Lozano

  7. Treatment of Fragile X Syndrome and Fragile X-associated Disorders

    Article • July 2014, Oxford University Press (OUP)

    Dr Reymundo Lozano, Reymundo Lozano

  8. Association between macroorchidism and intelligence in FMR1 premutation carriers

    Article • American Journal of Medical Genetics Part A, June 2014, Wiley

    Dr Reymundo Lozano, Reymundo Lozano

  9. A Novel ZRS Mutation Leads to Preaxial Polydactyly Type 2 in a Heterozygous Form and Werner Mesomelic Syndrome in a Homozygous Form

    Article • Human Mutation, June 2014, Hindawi Publishing Corporation

    Dr Reymundo Lozano, Reymundo Lozano

  10. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing

    Article • BMC Medical Genetics, May 2014, Springer Science + Business Media

    Dr Reymundo Lozano, Reymundo Lozano

  11. Targeted treatments in fragile X syndrome

    Article • Expert Opinion on Orphan Drugs, April 2014, Informa Healthcare

    Dr Reymundo Lozano, Reymundo Lozano

  12. Parent-delivered touchscreen intervention for children with fragile X syndrome

    Article • Intractable & Rare Diseases Research, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Dr Andrea Schneider, Reymundo Lozano

  13. Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases

    Article • Intractable & Rare Diseases Research, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Dr Andrea Schneider, Reymundo Lozano

  14. Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome

    Article • Intractable & Rare Diseases Research, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Reymundo Lozano

  15. Fragile X spectrum disorders

    Article • Intractable & Rare Diseases Research, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Reymundo Lozano

  16. Translational research guided by animal studies in Fragile X Disorders

    Article • Intractable & Rare Diseases Research, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Reymundo Lozano

  17. Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders

    Article • Intractable & Rare Diseases Research, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Reymundo Lozano

  18. Association of β-Defensin 1 Single Nucleotide Polymorphisms with Atopic Dermatitis

    Article • International Archives of Allergy and Immunology, November 2006, Karger Publishers

    Dr Reymundo Lozano, Reymundo Lozano